Effects of Low-Level Persistent Infection on Maintenance of Immunity by CD4 T Cell Subsets and Th1 Cytokines
CD4 T cells are required, along with antibodies, for complete protection from blood-stage infection with Plasmodium spp., which cause malaria. Without continuous exposure, as on emigration of people from endemic areas, protection from malaria decays. As in other persistent infections, low-level Plas...
Saved in:
Published in | Infection and immunity Vol. 91; no. 3; p. e0053122 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
15.03.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | CD4 T cells are required, along with antibodies, for complete protection from blood-stage infection with Plasmodium spp., which cause malaria. Without continuous exposure, as on emigration of people from endemic areas, protection from malaria decays. As in other persistent infections, low-level Plasmodium chabaudi infection protects the host from reinfection at 2 months postinfection, a phenomenon termed premunition. Premunition is correlated with T cell responses, rather than antibody levels. We previously showed that while both effector T cells (Teff) and memory T cells (Tmem) are present after infection, Teff protect better than Tmem. Here, we studied T cell kinetics post-infection by labeling dividing
T cells with 5-bromo-2'-deoxyuridine (BrdU) in infected
reporter mice. Large drops in specific T cell numbers and
cells upon clearance of parasites suggest a mechanism for decay of protection. Although protection decays, CD4 Tmem persist, including a highly differentiated CD27
effector memory (Tem) subset that maintains some
expression. In addition, pretreatment of chronically infected animals with neutralizing antibody to interferon gamma (IFN-γ) or with clodronate liposomes before reinfection decreases premunition, supporting a role for Th1-type immunity to reinfection. A pulse-chase experiment comparing chronically infected to treated animals showed that recently divided
T cells, particularly IFN-γ
TNF
IL-2
T cells, are promoted by persistent infection. These data suggest that low-level persistent infection reduces CD4
Tmem and multifunctional Teff survival, but promotes IFN-γ
TNF
IL-2
T cells and
terminally differentiated effector T cells, and prolongs immunity. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Present address: Michael M. Opata, Department of Biology, Appalachian State University, Boone, North Carolina, USA. Present address: Komi Gbedande, Center for Immunity and Inflammation, Rutgers New Jersey Medical School, Cancer Center, Newark, New Jersey, USA. Samad A. Ibitokou and Komi Gbedande contributed equally to this work. Author order was determined in order of seniority. The authors declare no conflict of interest. Present address: Samad A. Ibitokou, Fate Therapeutics, San Diego, California, USA. Present address: Victor H. Carpio, Alaunos Therapeutics, Houston, Texas, USA. Present address: Robin Stephens, Center for Immunity and Inflammation, Rutgers New Jersey Medical School, Cancer Center, Newark, New Jersey, USA. |
ISSN: | 0019-9567 1098-5522 |
DOI: | 10.1128/iai.00531-22 |